Physical Therapists in Canton, OH Accepting Medicare
93 Physical Therapists found. Showing 81 - 93
 Mr. Denis Scaia, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4426 Whipple Ave Nw, Canton, OH 44718 Phone: 330-492-1222 Fax: 330-492-1382 |
 Kelly Michelle Gregorich, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4645 Belpar St Nw, Canton, OH 44718 Phone: 330-493-4210 Fax: 330-493-4744 |
Sarah M Harp, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 4766 Belpar Street Nw, Canton, OH 44718 Phone: 330-244-1001 Fax: 330-244-1002 |
Dr. Andrew David Conrad, PT,DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2821 Woodlawn Ave Nw, Canton, OH 44708 Phone: 330-479-4805 |
Kyle Stephen Krempasky, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 4515 22nd St Nw, Canton, OH 44708 Phone: 330-477-7664 |
Jessica Ann Fonner, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3927 38th St Nw, Canton, OH 44718 Phone: 330-493-0096 |
Thomas M Krupar, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3625 Tuscarawas St W, Canton, OH 44708 Phone: 330-456-9977 Fax: 330-456-9979 |
Kristen Chavez, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 4766 Belpar St Nw, Canton, OH 44718 Phone: 330-244-1001 Fax: 330-244-1002 |
Mrs. Carol Ann Bartsch, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2424 Whipple Ave Nw, Canton, OH 44708 Phone: 330-478-2255 Fax: 330-478-0505 |
 Aegis Group Practice Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4515 22nd St Nw, Canton, OH 44708 Phone: 800-444-6845 |
Dr. Yevgeniy Berenshteyn, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1320 Mercy Dr Nw Fl 4, Canton, OH 44708 Phone: 330-489-1111 |
Miss Krista S Hodgkiss, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4645 Belpar St Nw, Canton, OH 44718 Phone: 330-493-4210 Fax: 330-493-4744 |
Dr. Ashley Marie Hutchings, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1320 Mercy Dr Nw, Canton, OH 44708 Phone: 330-489-1135 |
News Archive
New research offers ways in which investigators can reduce amount of Cd in foods
A number of environmental toxins pose considerable health threats to humans, and the heavy metal cadmium (Cd) ranks high on the list. Most of us are exposed to it through plant-derived foods such as grains and vegetables. Now, new research offers ways in which investigators can reduce the amount of Cd found in the food we eat, according to a review published online September 12th in the Cell Press journal Trends in Plant Science.
Merck's Phase III study shows efficacy results of tafluprost to treat ocular hypertension
Merck, known as MSD outside the United States and Canada, announced today that new Phase III data showed that patients with open-angle glaucoma or ocular hypertension, who were dosed once-daily with tafluprost, Merck's investigational, preservative-free prostaglandin analogue ophthalmic solution, experienced a reduction in intraocular pressure comparable to patients taking twice-daily preservative-free timolol maleate, a beta-adrenergic antagonist.
Multicenter study evaluates effectiveness of therapeutic hypothermia in reducing brain injury in children
When the heart is stopped and restarted, the patient's life may be saved but their brain is often permanently damaged. Therapeutic hypothermia, a treatment in which the patient's body temperature is lowered and maintained several degrees below normal for a period of time, has been shown to mitigate these harmful effects and improve survival in adults.
Pfizer/Medivation's AD drug Dimebon may garner peak year sales of $1.5 billion
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, if Pfizer/Medivation's Dimebon shows efficacy in two ongoing clinical trials in moderate to severe Alzheimer's disease that is equivalent to the impressive clinical trial data it has already shown to date in mild to moderate patients, these positive data would promote the use of Dimebon throughout the course of the disease.
› Verified 5 days ago
Physical Therapists
Chiropractors
Speech-Language Pathologists
Occupational Therapists
Optometrists
Podiatrists
Audiologists